Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022;79(2):107-113.
doi: 10.1024/0040-5930/a001335.

[Myelodysplastic/myeloproliferative neoplasia: a diagnostic and therapeutic challenge]

[Article in German]
Affiliations
Review

[Myelodysplastic/myeloproliferative neoplasia: a diagnostic and therapeutic challenge]

[Article in German]
Rudolf Benz. Ther Umsch. 2022.

Abstract

Myelodysplastic/myeloproliferative neoplasia: a diagnostic and therapeutic challenge Abstract. Myelodysplastic/myeloproliferative neoplasia is a WHO defined group of hematologic diseases. Difficulties diagnosing a distinct entity within this group are related to the resemblance of changes due to inflammation or dysplasia and proliferation. In addition, treatment is aiming to control the proliferation but should not aggravate dysplasia related cytopenia. In the article, we present an overview with a special focus on CMML as well as MDS/MPN-RS-T.

Zusammenfassung. Myelodysplastische/myeloproliferative Neoplasien sind nicht selten diagnostische und therapeutische Herausforderungen. Da Entzündungen gehäuft bei diesen Störungen gesehen werden können und zu ähnlichen Blutbildveränderungen führen, kann eine gesicherte Diagnose nicht selten erst im Verlauf gestellt werden. Aus therapeutischer Sicht stehen sich das Bremsen der Proliferation und die Stimulation der Zytopenie bei Dysplasie konträr gegenüber. Hypomethylinisierende Substanzen sind daher eine typische Therapie bei diesen Krankheitsbildern.

PubMed Disclaimer

MeSH terms

LinkOut - more resources